Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
ALERT

FREE Webinar for FA’s and RIA’s — Reserve Your Seat Now!

Mutualfunds logo

HGHAX Hartford Healthcare A

  • Fund
  • HGHAX
  • Price as of: Dec 02, 2016
  • $31.57
  • + $0.16
  • + 0.51%
  • Category
  • Health & Biotech Equities

HGHAX - Profile

Vitals

  • YTD Return -10.0%
  • 3 Yr Annualized Return 2.1%
  • 5 Yr Annualized Return 13.9%
  • Net Assets $1.39 B
  • Holdings in Top 10 38.3%

52 WEEK LOW AND HIGH

$31.57
$28.31
$40.10

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.28%

SALES FEES

  • Front Load 5.50%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 39.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$2,000

IRA

$2,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -10.0%
  • 3 Yr Annualized Total Return 12.7%
  • 5 Yr Annualized Total Return 29.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.46%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name The Hartford Healthcare Fund
  • Fund Family Name Hartford Mutual Funds
  • Inception Date May 01, 2000
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager Ann C. Gallo

Fund Description

Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The focus of the fund's investment process is stock selection through fundamental analysis.

HGHAX - Performance

Return Ranking - Trailing

Period HGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -10.0% -30.9% 7.4% 33.93% 2
1 Yr -21.8% -31.1% 18.4% 81.98% 5
3 Yr 2.1% * -17.6% 17.2% 54.63% 3
5 Yr 13.9% * -5.6% 21.9% 46.53% 3
10 Yr 6.3% * -2.7% 14.3% 70.73% 4

* Annualized


Return Ranking - Calendar

Period HGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -1.9% -20.4% 13.8% 44.55% 3
2014 18.1% -5.9% 31.5% 37.27% 2
2013 49.4% 0.0% 65.2% 19.27% 1
2012 19.8% -5.3% 36.5% 30.10% 2
2011 7.7% -15.5% 18.8% 29.41% 2

Total Return Ranking - Trailing

Period HGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -10.0% -23.6% 7.4% 34.23% 2
1 Yr -10.5% -30.7% 10.5% 40.91% 3
3 Yr 12.7% * -17.6% 19.3% 14.81% 1
5 Yr 29.0% * -5.6% 147.5% 20.20% 1
10 Yr 15.3% * -2.3% 37.3% 24.05% 2

* Annualized


Total Return Ranking - Calendar

Period HGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 14.4% -16.6% 20.7% 9.17% 1
2014 35.2% -5.8% 55.3% 51.38% 3
2013 79.1% 0.0% 398.7% 42.59% 3
2012 35.8% -5.1% 475.8% 53.00% 3
2011 14.9% -10.2% 2296.2% 46.39% 3

NAV & Total Return History

HGHAX - Holdings

Filings data as of: Oct 31, 2016

Concentration Analysis

HGHAX Category Low Category High HGHAX % Rank Quintile
Net Assets 1.39 B 20.5 M 43.6 B 13.39% 3
Number of Holdings 92 31 345 13.39% 3
Net Assets in Top 10 533 M 9.55 M 20.9 B 18.75% 4
Weighting of Top 10 38.3% 21.8% 71.5% 23.21% 4

Top 10 Holdings

  1. Bristol-Myers Squibb Company 4.55%
  2. Allergan PLC 4.92%
  3. Medtronic PLC 5.35%
  4. UnitedHealth Group Inc 5.77%
  5. AstraZeneca PLC ADR 2.56%
  6. Boston Scientific Corp 3.09%
  7. Celgene Corp 3.38%
  8. Abbott Laboratories 3.01%
  9. Eli Lilly and Co 3.06%
  10. Thermo Fisher Scientific Inc 2.61%

Asset Allocation

Weighting Category Low Category High HGHAX % Rank Quintile
Stocks
97.98% 82.12% 103.35% 16.96% 3
Cash
1.99% 0.00% 16.35% 11.61% 3
Other
0.04% -3.35% 10.27% 14.29% 3
Convertible Bonds
0.00% 0.00% 0.38% 3.57% 3
Preferred Stocks
0.00% 0.00% 0.96% 4.46% 4
Bonds
0.00% 0.00% 1.91% 5.36% 4

Stock Sector Breakdown

Weighting Category Low Category High HGHAX % Rank Quintile
Healthcare
93.22% 13.15% 99.87% 18.75% 3
Technology
3.46% 0.00% 64.83% 8.04% 2
Industrials
0.85% 0.00% 13.35% 8.04% 2
Consumer Defense
0.44% 0.00% 2.38% 8.93% 2
Financial Services
0.00% 0.00% 1.00% 6.25% 4
Real Estate
0.00% 0.00% 1.97% 2.68% 3
Energy
0.00% 0.00% 0.00% 0.89% 3
Communication Services
0.00% 0.00% 1.73% 1.79% 4
Utilities
0.00% 0.00% 1.10% 1.79% 3
Consumer Cyclical
0.00% 0.00% 3.21% 7.14% 4
Basic Materials
0.00% 0.00% 4.92% 4.46% 4

Stock Geographic Breakdown

Weighting Category Low Category High HGHAX % Rank Quintile
US
87.97% 60.81% 99.87% 14.29% 2
Non US
10.01% 0.00% 41.10% 17.86% 3

HGHAX - Expenses

Operational Fees

HGHAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.28% 0.10% 4.31% 44.64% 3
Management Fee 0.85% 0.08% 1.25% 6.25% 4
12b-1 Fee 0.25% 0.00% 1.00% 8.97% 2
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

HGHAX Fees (% of AUM) Category Low Category High HGHAX Rank Quintile
Front Load 5.50% 3.50% 5.75% 7.69% 2
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

HGHAX Fees (% of AUM) Category Low Category High HGHAX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HGHAX Fees (% of AUM) Category Low Category High HGHAX Rank Quintile
Turnover 39.00% 7.00% 249.00% 16.96% 3

HGHAX - Distributions

Dividend Yield Analysis

HGHAX Category Low Category High HGHAX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

HGHAX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

HGHAX Category Low Category High HGHAX % Rank Quintile
Net Income Ratio -0.46% -2.22% 1.40% 37.50% 3

Capital Gain Distribution Analysis

HGHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

HGHAX - Managers

Ann C. Gallo

Manager

Start Date

May 01, 2000

Tenure

16.51

Tenure Rank

2.6%

Ann C. Gallo, Senior Vice President, Partner, and Global Industry Analyst, is involved in portfolio management and securities analysis. Prior to joining Wellington Management in 1998, Ann was a health care analyst with BT Alex. Brown (1995 — 1998). She was an investment banker and a health care analyst at Piper Jaffray in Minneapolis (1992 — 1995). Previously, she was a financial analyst with Citibank N.A. (1991 — 1992) and an accountant with Coopers & Lybrand (1987 — 1989). Ann received her MS from the Massachusetts Institute of Technology and her BS in accounting from Boston College


Jean M. Hynes

Manager

Start Date

May 01, 2000

Tenure

16.51

Tenure Rank

2.6%

Jean M. Hynes, CFA, Senior Vice President, Managing Partner, and Global Industry Analyst, is involved in portfolio management and securities analysis at Wellington Management. Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.


Kirk J. Mayer

Manager

Start Date

May 01, 2000

Tenure

16.51

Tenure Rank

2.6%

Kirk, CFA,Senior Vice President, Partner, and Global Industry Analyst, is involved in portfolio management and securities analysis. Prior to joining the Wellington Management in 1998, Kirk worked for Lockheed Martin Corporation as a manager in Microelectronics Production and as a quality assurance engineer (1992 — 1996). Before that, Kirk worked in the Manufacturing Management Program at General Electric Company (1990 — 1992). Kirk received his MBA from the University of Pennsylvania and his BS in electrical engineering and BS in management from Worcester Polytechnic Institute.he holds CFA.


Robert L. Deresiewicz

Manager

Start Date

Dec 31, 2004

Tenure

11.84

Tenure Rank

5.7%

Robert is Senior Vice President, Partner, and Global Industry Analyst. Bob is a biotechnology analyst and member of Wellington's health care team within Global Industry Research. Prior to joining Wellington Management in 2000, Bob was an Assistant Professor of Medicine at the Harvard Medical School, and an Associate Physician in the Division of Infectious Diseases at the Brigham and Women's Hospital (1990 — 1998). Bob received his MBA from the Harvard Business School (2000), his MD from the Mount Sinai School of Medicine, and his BA in biochemistry summa cum laude from Columbia University.


Tenure Analysis

Category Low

0.0

Category High

19.1

Category Average

8.78

Category Mode

4.8